Both tirzepatide and semaglutide are breakthrough drugs in managing type 2 diabetes and obesity
Important examples include verapamil, diltiazem, digoxin, clonidine, certain antiarrhythmics, and medicines used during anesthesia
Patients with certain genetic profiles may achieve results at lower doses or may require more frequent monitoring when adjusting their schedule
Interim commissioning guidance: implementation of the NICE technology appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro) for the management of obesity
A board-certified provider, Eddie Hughes, FNP-BC, who personally oversees your care Individualized, lab-guided dosing rather than a one-size-fits-all protocol Peptides obtained through medical sourcing with laboratory analysis for purity and consistency Ongoing medical supervision and monitoring A focus on education instead of a sales pitch Peptide therapy also connects to the rest of what we do across the Tri-Cities, from mens health and hormone optimization to regenerative medicine, so your plan can fit the bigger picture of your health rather than sit off to the side